UK genomics report calls for strategic innovation
This article was originally published in Scrip
Executive Summary
The UK's Human Genomics Strategy Group (HGSG), established as part of the UK government's response to the 2009 House of Lords Inquiry into genomic medicine, has made a series of recommendations that it believes will enable the healthcare system in the UK - and particularly the National Health Service (NHS) - to benefit from the mainstream adoption of genomic technology.